Clinical Trials

Movano Health kicks off cuffless blood pressure device study

Movano Health announced that it commenced a blood pressure clinical trial with its new cuffless wrist wearable. Pleasanton, California-based Movano designed its updated device to...

Median Technologies’ eyonis™ screening meets primary endpoint in RELIVE clinical trial

Median Technologies announced that eyonis™ LCS, its wholly owned proprietary AI/ML-based CADe/CADx Software as a Medical Device (SaMD) for lung cancer screening, met the...

Aethlon Medical treats first subject with Hemopurifier device in Australia

US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer trial. Designed for subjects with solid tumours, the...

BrightHeart’s AI demonstrates promise in congenital heart defect detection

BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies. The French company’s AI software received 510(k) clearance...

Swiss startup Risklick launches AI-based software for medical device clinical trials

Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of...

Pulse Biosciences touts positive results from PFA early feasibility study

Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for the treatment of atrial...

Patient enrollment underway for STIMIT’s diaphragm neurostimulation device

STIMIT AG is enrolling patients in a U.S. Food and Drug Administration Investigational Device Exemption (IDE) clinical trial designed to evaluate its noninvasive diaphragm...

Mainstay Medical study demonstrates benefit of neurostimulation for back pain

Mainstay Medical’s one-year study of its neurostimulation system for the treatment of chronic low back pain (CLBP) has demonstrated the system’s value over the...

CardioFocus has positive pulsed field ablation data for its Centauri system

CardioFocus published 12-month data from a study of its pulsed field ablation (PFA) system. ECLIPSE AF, evaluated the safety and performance of the CardioFocus Centauri...
1...101112...59Page 11 of 59

Latest articles